Hemodynamic analysis and efficient control of ischemic heart in chronically instrumented dogs

长期使用仪器的狗的血流动力学分析和缺血性心脏的有效控制

基本信息

  • 批准号:
    10470319
  • 负责人:
  • 金额:
    $ 8.06万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

This study was carried out to establish the model of stunned myocardium with chronically instrumented dogs, and to analyze systemic and coronary hemodynamics under administration of several anesthetics and vasoactive drugs using the computer-based cardiovascular measurement system including the analysis of left ventricular pressure-volume relationship.The direct effects of several anesthetics on myocardial contractility were studied. The, direct myocardial depressant effect of etomidate, ketamine and propofol was dose dependent. Fentanyl had no negative inotropic effect. The hemodynamic actions of kromakalim were studied under the conscious state and during isoflurane anesthesia. The coronary vasodilating effects of isoflurane and cromakalim were basically additive until cromakalim exerted the maximal effects. The combined effects of dantrolen with propofol on the systemic and coronary hemodynamics were studied. A clinical dose of dantrolen reversed the decrease in heart rate, coronary … More blood flow and mean arterial pressure caused by propofol anesthesia.The hemodynamic and cardioprotective effects of sevoflurane in stunned myocardium were studied. Sevoflurane had a cardioprotective effect mediated through activation of mitochondria! K^ channels. The efficacy of MQ-154 after sevoflurane anesthesia for myocardial contractile function and oxygen consumption on stunned myocardium were studied. The combination of low-dose MCI-154 with sevoflurane could synergisucally act to produce full recovery of myocardial contraction without increase in myocardial oxygen consumption and heart rate after ischemia/reperfusion.The effects of sevoflurane on myocardial contractility and systemic and coronary hemodynamics, as compared with the effects of isoflurane under the same cardiac work condition, were studied. Myocardial depressant effects were comparable between sevoflurane and isoflurane, and both systemic and coronary vasodilatory effects of isoflurane were greater than those of sevoflurane. The cardiovascular effects of sevoflurane under acute normovolemic hemodilution were studied. Acute normovolemic hemodilution was beneficial during sevoflurane anesthesia with respect to the left ventricular-arterial coupling and mechanical efficiency. Less
本研究建立了犬顿抑心肌模型,应用计算机心血管测量系统,分析了几种麻醉药和血管活性药物对犬全身和冠状动脉血流动力学的影响,包括左心室压力-容积关系的分析,并探讨了几种麻醉药对心肌收缩力的直接影响。依托咪酯、氯胺酮和丙泊酚的直接心肌抑制作用呈剂量依赖性。芬太尼无负性肌力作用。本文研究了在清醒状态下和异氟醚麻醉时克罗卡林的血流动力学作用。异氟烷和色满卡林的冠状动脉血管扩张作用基本上是相加的,直到色满卡林发挥最大作用。观察丹曲伦与异丙酚合用对全身及冠状动脉血流动力学的影响。临床剂量的丹曲伦逆转了心率、冠状动脉 ...更多信息 观察七氟醚对顿抑心肌血流动力学及心肌保护作用。七氟烷具有通过激活线粒体介导的心脏保护作用!K^通道。观察MQ-154对七氟醚麻醉后顿抑心肌收缩功能和氧耗的影响。本文研究了七氟醚与小剂量MCI-154联合应用对缺血/再灌注后心肌收缩功能的影响,并与异氟醚在相同心脏作功条件下对心肌收缩功能、全身和冠状动脉血流动力学的影响进行了比较。七氟烷和异氟烷的心肌舒张作用相当,异氟烷的全身和冠状血管舒张作用均大于七氟烷。本文研究了七氟醚在急性等容血液稀释条件下的心血管效应。急性等容血液稀释在七氟烷麻醉期间有利于左心室-动脉耦合和机械效率。少

项目成果

期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hara T, Tomiyasu S, Hasuo H, Ureshino Y, Sumikawa K: "Cardioprotective effects of a novel KATP channel opener, JTV506, in stunned myocardium in dogs"Anesthesiology. 89. A607 (1998)
Hara T、Tomiyasu S、Hasuo H、Ureshino Y、Sumikawa K:“新型 KATP 通道开放剂 JTV506 对犬心肌顿抑的心脏保护作用”麻醉学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomiyasu S, Hara T, Hasuo H, Sumikawa K: "Vasopressin antagonist improves functional recovery of stunned myocardium in dogs"Anesthesiology. 89. A610 (1998)
Tomiyasu S、Hara T、Hasuo H、Sumikawa K:“加压素拮抗剂可改善狗致昏心肌的功能恢复”麻醉学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sumikawa K, Zhang S, Sakai K, Hasuo H, Shibata O: "Hemodynamic interaction of dantrolene and propofol in chronically instrumented dogs"Anesthesiology. 91. A661 (1999)
Sumikawa K、Zhang S、Sakai K、Hasuo H、Shibata O:“长期使用仪器的狗中丹曲林和丙泊酚的血流动力学相互作用”麻醉学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sakai K, Zhang, Ureshio H, Tomiyasu S, Sumikawa K: "Interaction of isoflurane and cromakalim, a K-ATP channel opener, on coronary and systemic haemodynamics in chronically instrumented dogs"Acta Anaesthesiologica Scandinavica. 44. 1122-1127 (2000)
Sakai K、Zhang、Ureshio H、Tomiyasu S、Sumikawa K:“异氟烷和 Cromakalim(一种 K-ATP 通道开放剂)对长期使用仪器的狗的冠状动脉和全身血流动力学的相互作用”Acta Anaesthesiologica Scandinavica。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hara T,Tomiyasu S,et al.: "Cardioprotective effects of a novel KATP channel opener,JTV506,in stunned myocardium in dogs." Anesthesiology. 89・3A. A607 (1998)
Hara T、Tomiyasu S 等人:“新型 KATP 通道开放剂 JTV506 对狗的心肌损伤的保护作用”89·3A607。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUMIKAWA Koji其他文献

SUMIKAWA Koji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUMIKAWA Koji', 18)}}的其他基金

Conquest of myocardial ischemia reperfusion injury-Control of RISK pathway and antioxidant mechanism-
攻克心肌缺血再灌注损伤-RISK通路调控与抗氧化机制-
  • 批准号:
    19390406
  • 财政年份:
    2007
  • 资助金额:
    $ 8.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pharmacological preconditioning strategy based on organ specific mechanisms
基于器官特异性机制的药理预处理策略
  • 批准号:
    16390453
  • 财政年份:
    2004
  • 资助金额:
    $ 8.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pharmacological control of myocardial contractile function on myocardial stunning
心肌收缩功能对心肌顿抑的药理学控制
  • 批准号:
    13470322
  • 财政年份:
    2001
  • 资助金额:
    $ 8.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Hemodynamic Interactions of Anesthetics and K Channel Openers in Chronically Instrumented Dogs
长期接受仪器治疗的狗中麻醉药和 K 通道开放剂的血流动力学相互作用
  • 批准号:
    07457359
  • 财政年份:
    1995
  • 资助金额:
    $ 8.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
用于骨髓抽吸物实时充分性分析的深紫外显微镜
  • 批准号:
    10761397
  • 财政年份:
    2023
  • 资助金额:
    $ 8.06万
  • 项目类别:
Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma
整合基于液体活检的表观遗传学和成像方式来评估多发性骨髓瘤的疾病反应
  • 批准号:
    10651370
  • 财政年份:
    2023
  • 资助金额:
    $ 8.06万
  • 项目类别:
Platelet-mediated mechanisms of placental and systemic hypercoagulability in preeclampsia
先兆子痫胎盘和全身高凝状态的血小板介导机制
  • 批准号:
    10509032
  • 财政年份:
    2022
  • 资助金额:
    $ 8.06万
  • 项目类别:
Platelet-mediated mechanisms of placental and systemic hypercoagulability in preeclampsia
先兆子痫胎盘和全身高凝状态的血小板介导机制
  • 批准号:
    10686921
  • 财政年份:
    2022
  • 资助金额:
    $ 8.06万
  • 项目类别:
ECmo hemoSTAtic Transfusions In Children (ECSTATIC)
儿童 ECmo 止血输血 (ECSTATIC)
  • 批准号:
    10527446
  • 财政年份:
    2022
  • 资助金额:
    $ 8.06万
  • 项目类别:
von Willebrand Factor in Traumatic Brain Injury and Associated Coagulopathy
外伤性脑损伤和相关凝血病中的冯维勒布兰德因子
  • 批准号:
    10599316
  • 财政年份:
    2020
  • 资助金额:
    $ 8.06万
  • 项目类别:
Photoacoustic Microscopy of the Awake Mouse Brain
清醒小鼠大脑的光声显微镜
  • 批准号:
    9914138
  • 财政年份:
    2020
  • 资助金额:
    $ 8.06万
  • 项目类别:
von Willebrand Factor in Traumatic Brain Injury and Associated Coagulopathy
外伤性脑损伤和相关凝血病中的冯维勒布兰德因子
  • 批准号:
    10370366
  • 财政年份:
    2020
  • 资助金额:
    $ 8.06万
  • 项目类别:
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
使用 BCL-2 抑制剂 Venetoclax 和优化的 10 天地西他滨方案靶向高危 AML 和 MDS 中的细胞凋亡
  • 批准号:
    10654631
  • 财政年份:
    2019
  • 资助金额:
    $ 8.06万
  • 项目类别:
Maximizing transfusion efficacy through nitric oxide enhancement strategies
通过一氧化氮增强策略最大化输血功效
  • 批准号:
    10009828
  • 财政年份:
    2019
  • 资助金额:
    $ 8.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了